Mapping the Prevalence of Lynch Syndrome in the Ceará—Northeast of Brazil
Clinical Genetics · 2026-04 · 109 (4) · 630-638
DOI: 10.1111/cge.70082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 27.09.2025. Verfasst von Maria Claudia Dos Santos Luciano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Do Câncer Do Ceará/Faculdade Rodolfo Teófilo, Fortaleza, Brazil. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Oncology Care Support Program (PRONON).
Abstract (Originalsprache)
Lynch syndrome (LS) is an autosomal dominant hereditary disorder that increases the risk of various cancers, especially colorectal (CRC) and endometrial cancer (EC). It results from pathogenic variants in mismatch repair (MMR) genes—primarily MLH1 , MSH2 , MSH6 , and PMS2 . Population‐specific variant frequencies emphasize the need for localized genetic studies.
Methods
This study investigated LS prevalence in Ceará, Northeast Brazil, analyzing 150 patients: 130 with CRC, 13 with endometrial cancer, and 7 with other tumors but a family history of LS‐associated cancers. Researchers used next‐generation sequencing (NGS) to examine 131 genes linked to hereditary cancer syndromes. Variants were classified as Lynch‐syndrome associated (MMR genes) or non‐Lynch‐associated (non‐MMR genes). Detection rates varied from 1.18 to 5.07 per 100,000 people; pathogenic variant prevalence ranged from 0 to 1.96 per 100,000 across microregions. Overall, the prevalence of MMR variants was 0.56 per 100,000, and 0.34 for non‐MMR variants. MSH2 showed the highest number of pathogenic or likely pathogenic variants, followed by MSH6 , PMS2 , and MLH1 . The study found a particular geographic distribution of LS‐related variants. One novel MSH6 variant and two unreported non–Lynch variants ( APC and SMAD4 ) were identified.
Conclusions
These findings highlight three novel variants in MSH6 , APC , and SMAD4 , and indicate that Ceará has a higher diversity and a unique spectrum of variants. This reinforces the importance of regional genetic screening and suggests the need to expand testing access, especially in high‐risk areas, to improve the early detection and prevention of hereditary cancers in Northeast Brazil.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Do Câncer Do Ceará/Faculdade Rodolfo Teófilo, Fortaleza, Brazil.
ORCID-Profile: Maria Claudia Dos Santos Luciano, Francisca Fernanda Barbosa Oliveira
Förderung
- National Oncology Care Support Program (PRONON)
Zitieren
APA
Dos Santos Luciano, M. C., de Barros Silva, P. G., de Sant'Ana, R. O., de Albuquerque, C. G. P., Oliveira, F. F. B., da Silveira Bitencourt, F., de Lima Silva Fernandes, I. J., Moura, J. F. B., & Bezerra, M. J. B. (2026). Mapping the Prevalence of Lynch Syndrome in the Ceará—Northeast of Brazil. Clinical Genetics, 109(4), 630-638. https://doi.org/10.1111/cge.70082
Vancouver
Dos Santos Luciano MC, de Barros Silva PG, de Sant'Ana RO, de Albuquerque CGP, Oliveira FFB, da Silveira Bitencourt F, et al. Mapping the Prevalence of Lynch Syndrome in the Ceará—Northeast of Brazil. Clinical Genetics. 2026;109(4):630-638. doi:10.1111/cge.70082
BibTeX
@article{DosSantosLuciano2026,
author = {Dos Santos Luciano, Maria Claudia and de Barros Silva, Paulo Goberlanio and de Sant'Ana, Rosane Oliveira and de Albuquerque, Clarissa Gondim Picanço and Oliveira, Francisca Fernanda Barbosa and da Silveira Bitencourt, Flavio and de Lima Silva Fernandes, Isabelle Joyce and Moura, José Fernando Bastos and Bezerra, Maria Júlia Barbosa},
title = {Mapping the Prevalence of Lynch Syndrome in the Ceará—Northeast of Brazil},
journal = {Clinical Genetics},
year = {2026},
volume = {109},
number = {4},
pages = {630--638},
doi = {10.1111/cge.70082}
}
EUVIMED